| Emily Sue Kenner, MD | |
|
830 Thomas More Pkwy Ste 202, Edgewood, KY 41017-5103 | |
| (513) 487-5305 | |
| Not Available |
| Full Name | Emily Sue Kenner |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 16 Years |
| Location | 830 Thomas More Pkwy Ste 202, Edgewood, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225201858 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 44383 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davita - Williamstown Dialysis | Williamstown, KY | Dialysis facility |
| Davita-turfway Pd Training | Florence, KY | Dialysis facility |
| Davita - Turfway Dialysis | Florence, KY | Dialysis facility |
| Davita-walton Dialysis | Walton, KY | Dialysis facility |
| Davita - Crestview Hills Dialysis | Crestview hills, KY | Dialysis facility |
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| St Elizabeth Florence | Florence, KY | Hospital |
| St Elizabeth Grant | Williamstown, KY | Hospital |
| St Elizabeth Ft Thomas | Fort thomas, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kidney And Hypertension Center Inc | 9830099985 | 46 |
| Kidney And Hypertension Center Inc | 9830099985 | 46 |
News Archive
BioSante Pharmaceuticals, Inc., today announced it sold to Cold Genesys, Inc. exclusive, worldwide rights to develop and commercialize its oncolytic virus technology. The technology includes CG0070, a replication-competent adenovirus that has completed a Phase I clinical trial for treatment of superficial bladder cancer. In exchange for the technology, BioSante received a 19.9 percent ownership position in Cold Genesys and a $95,000 upfront cash payment and is eligible to receive future milestone and royalty payments.
Surviving heart failure calls for lifestyle changes, taking medications and following doctor's orders. Some of the 5 million heart failure patients have trouble adhering to these changes and end up returning to the hospital.
A long non-coding RNA (lincRNA) - called lincRNA-EPS - responsible for regulating innate immunity has been identified by a team of scientists at the University of Massachusetts Medical School.
LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools, developed by Dr. Manuel S. Rodriguez of the proteomics unit of the CICbioGUNE in Spain, will be launched in October 2009.
Sen. Cory Gardner, a Republican running in a tight race for reelection in Colorado, says he wants to protect people with medical conditions.
› Verified 2 days ago
| Entity Name | Kidney And Hypertension Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306944871 PECOS PAC ID: 9830099985 Enrollment ID: O20040521000228 |
News Archive
BioSante Pharmaceuticals, Inc., today announced it sold to Cold Genesys, Inc. exclusive, worldwide rights to develop and commercialize its oncolytic virus technology. The technology includes CG0070, a replication-competent adenovirus that has completed a Phase I clinical trial for treatment of superficial bladder cancer. In exchange for the technology, BioSante received a 19.9 percent ownership position in Cold Genesys and a $95,000 upfront cash payment and is eligible to receive future milestone and royalty payments.
Surviving heart failure calls for lifestyle changes, taking medications and following doctor's orders. Some of the 5 million heart failure patients have trouble adhering to these changes and end up returning to the hospital.
A long non-coding RNA (lincRNA) - called lincRNA-EPS - responsible for regulating innate immunity has been identified by a team of scientists at the University of Massachusetts Medical School.
LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools, developed by Dr. Manuel S. Rodriguez of the proteomics unit of the CICbioGUNE in Spain, will be launched in October 2009.
Sen. Cory Gardner, a Republican running in a tight race for reelection in Colorado, says he wants to protect people with medical conditions.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Sue Kenner, MD 4600 Montgomery Rd Ste 105, Cincinnati, OH 45212-2600 Ph: (513) 487-5305 | Emily Sue Kenner, MD 830 Thomas More Pkwy Ste 202, Edgewood, KY 41017-5103 Ph: (513) 487-5305 |
News Archive
BioSante Pharmaceuticals, Inc., today announced it sold to Cold Genesys, Inc. exclusive, worldwide rights to develop and commercialize its oncolytic virus technology. The technology includes CG0070, a replication-competent adenovirus that has completed a Phase I clinical trial for treatment of superficial bladder cancer. In exchange for the technology, BioSante received a 19.9 percent ownership position in Cold Genesys and a $95,000 upfront cash payment and is eligible to receive future milestone and royalty payments.
Surviving heart failure calls for lifestyle changes, taking medications and following doctor's orders. Some of the 5 million heart failure patients have trouble adhering to these changes and end up returning to the hospital.
A long non-coding RNA (lincRNA) - called lincRNA-EPS - responsible for regulating innate immunity has been identified by a team of scientists at the University of Massachusetts Medical School.
LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools, developed by Dr. Manuel S. Rodriguez of the proteomics unit of the CICbioGUNE in Spain, will be launched in October 2009.
Sen. Cory Gardner, a Republican running in a tight race for reelection in Colorado, says he wants to protect people with medical conditions.
› Verified 2 days ago
Alice Hall, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-8074 Fax: 859-301-4945 | |
Colleen M Darnell, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000 Fax: 859-301-4001 | |
Charles M Bernstein, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, St. Elizabeth Healthcare, Edgewood, KY 41017 Phone: 859-301-2423 Fax: 859-301-2066 | |
Vidya Rajaram Devarajan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-757-4446 Fax: 859-344-1999 | |
Dr. Minsig Choi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000 Fax: 859-301-4001 | |
Robert J Wagner, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-8074 Fax: 859-301-4945 | |
Ryan Daniel Weprin, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-8074 Fax: 859-301-4945 |